International Clinical Trial: A Single-Arm, Exploratory, Multicenter Clinical Study of Iparomlimab and Tuvonralimab Injection Combined with Chemotherapy as Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126520) titled 'A Single-Arm, Exploratory, Multicenter Clinical Study of Iparomlimab and Tuvonralimab Injection Combined with Chemotherapy as Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma' on June 10.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Shandong First Medical University and Shandong Academy of Medical Sciences (Shandong Cancer Hospital &Institute)

Condition: Esophageal squamous cell carcinoma (ESCC)

Intervention: Experimental Group:Iparomlimab and Tuvonralimab + Paclitaxel + Carboplatin Iparomlimab and Tuvonralimab, 5mg/kg, Q3W, intravenous infusion Paclitaxel, 175mg/m2 ...